Parameters
- 168bladzijden
- 6 uur lezen
Meer over het boek
With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.
Een boek kopen
Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors, John Preston Feighner, W. F. Boyer
- Taal
- Jaar van publicatie
- 1991
- product-detail.submit-box.info.binding
- (Hardcover)
Betaalmethoden
Nog niemand heeft beoordeeld.
- Titel
- Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors
- Ondertitel
- The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
- Taal
- Engels
- Auteurs
- John Preston Feighner, W. F. Boyer
- Uitgever
- Wiley
- Jaar van publicatie
- 1991
- Formaat
- Hardcover
- Aantal pagina's
- 168
- ISBN10
- 0471928909
- ISBN13
- 9780471928904
- Reeks
- Tags
- Non-fictie, Sociale Wetenschappen, Gezondheid & Medisch, Psychologie, Geestelijke Gezondheid, Psychiatrie, Farmacologie
- Aantekening
- With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.